4//SEC Filing
AKKARAJU SRINIVAS 4
Accession 0001253170-25-000021
CIK 0001847367other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 7:13 PM ET
Size
11.2 KB
Accession
0001253170-25-000021
Insider Transaction Report
Form 4
ALUMIS INC.ALMS
AKKARAJU SRINIVAS
Director
Transactions
- Purchase
Common Stock
2025-12-05$8.95/sh+64,969$581,473→ 1,143,845 total(indirect: By Samsara Opportunity Fund, L.P.) - Purchase
Common Stock
2025-12-05$10.01/sh+70,028$700,980→ 1,213,873 total(indirect: By Samsara Opportunity Fund, L.P.) - Purchase
Common Stock
2025-12-05$10.73/sh+51,380$551,307→ 1,265,253 total(indirect: By Samsara Opportunity Fund, L.P.)
Holdings
- 4,491,731(indirect: By Samsara BioCapital, L.P.)
Common Stock
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.48 to $9.4793 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Shares are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.48 to $10.47 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.48 to $11.005 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F5]Shares are directly held by Samsara BioCapital LP. ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Documents
Issuer
ALUMIS INC.
CIK 0001847367
Entity typeother
Related Parties
1- filerCIK 0001253170
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 7:13 PM ET
- Size
- 11.2 KB